Home
>
National Drug Code (NDC)
>
Chlordiazepoxide Hydrochloride
Chlordiazepoxide Hydrochloride - 51079-374-20 - (Chlordiazepoxide Hydrochloride)
Drug Information of Chlordiazepoxide Hydrochloride
| Product NDC: | 51079-374 |
| Proprietary Name: | Chlordiazepoxide Hydrochloride |
| Non Proprietary Name: | Chlordiazepoxide Hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Chlordiazepoxide Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Chlordiazepoxide Hydrochloride
| Product NDC: | 51079-374 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084768 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120810 |
Package Information of Chlordiazepoxide Hydrochloride
| Package NDC: | 51079-374-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-374-20) > 1 CAPSULE in 1 BLISTER PACK (51079-374-01) |
NDC Information of Chlordiazepoxide Hydrochloride
| NDC Code | 51079-374-20 |
| Proprietary Name | Chlordiazepoxide Hydrochloride |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-374-20) > 1 CAPSULE in 1 BLISTER PACK (51079-374-01) |
| Product NDC | 51079-374 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlordiazepoxide Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120810 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |
